{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:49:14Z","timestamp":1788565754016,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.diabres.2022.110031","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T22:49:17Z","timestamp":1659653357000},"page":"110031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area"],"prefix":"10.1016","volume":"191","author":[{"given":"Gabriel","family":"Gimenez-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Vlacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Mata-Cases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.110031_b0005","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s00125-021-05571-8","article-title":"Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults","volume":"64","author":"Green","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.110031_b0010","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jdiacomp.2016.03.032","article-title":"Diabetes distress in adults with type 1 diabetes: prevalence, incidence and change over time","volume":"30","author":"Fisher","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2022.110031_b0015","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/jc.2016-2478","article-title":"T1D Exchange Clinic Network. Autoimmune diseases in children and adults with Type 1 diabetes from the T1D exchange clinic registry","volume":"101","author":"Hughes","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2022.110031_b0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/1753-0407.12856","article-title":"High prevalence of comorbid autoimmune diseases in adults with Type 1 diabetes from the HealthFacts database","volume":"11","author":"Bao","year":"2019","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabres.2022.110031_b0025","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2337\/dc19-2429","article-title":"FinnDiane Study Group. every fifth individual with type 1 diabetes suffers from an additional autoimmune disease: a Finnish nationwide study","volume":"43","author":"M\u00e4kimattila","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110031_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164977","article-title":"The humanistic burden of type 1 diabetes mellitus in Europe: examining health outcomes and the role of complications","volume":"11","author":"Ryd\u00e9n","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2022.110031_b0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/dme.13266","article-title":"Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up","volume":"34","author":"Adamsson Eryd","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2022.110031_b0040","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00125-019-4812-6","article-title":"Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study","volume":"62","author":"Bjerg","year":"2019","journal-title":"Diabetologia"},{"issue":"109038","key":"10.1016\/j.diabres.2022.110031_b0045","article-title":"RENACED-DT1 research group. glycemic control, treatment and complications in patients with type 1 diabetes amongst healthcare settings in Mexico","volume":"180","author":"Antonio-Villa","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.110031_b0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fendo.2020.00431","article-title":"Does Hashimoto's thyroiditis increase the risk of cardiovascular disease in young Type 1 diabetic patients?","volume":"11","author":"G\u0142owinska-Olszewska","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2022.110031_b0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5114\/pedm.2020.101809","article-title":"Thyroid diseases - ally or enemy of type 1 diabetes in children and adolescents?","volume":"27","author":"Ogarek","year":"2021","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"10.1016\/j.diabres.2022.110031_b0060","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.114.009990","article-title":"Chronic inflammatory disorders and risk of Type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study","volume":"130","author":"Dregan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2022.110031_b0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.mcna.2021.11.010","article-title":"Cardio-Rheumatology: Prevention of cardiovascular disease in inflammatory disorders","volume":"106","author":"Nona","year":"2022","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.diabres.2022.110031_b0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/jwh.2019.7935","article-title":"Sex differences in autoimmune multimorbidity in Type 1 diabetes mellitus and the risk of cardiovascular and renal disease: a longitudinal study in the United States, 2001\u20132017","volume":"29","author":"Rogers","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.diabres.2022.110031_b0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jcjd.2020.10.010","article-title":"The prevalence of autoimmune diseases in longstanding diabetes: results from the Canadian study of longevity in adults with Type 1 diabetes","volume":"45","author":"Cardinez","year":"2021","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.diabres.2022.110031_b0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40618-019-01171-x","article-title":"Does autoimmune hypothyroidism increase the risk of neurovascular complications in Type 1 diabetes?","volume":"43","author":"Rogowicz-Frontczak","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.diabres.2022.110031_b0085","doi-asserted-by":"crossref","first-page":"e3381","DOI":"10.1210\/clinem\/dgab376","article-title":"Characteristics of patients with Type 1 diabetes and additional autoimmune disease in the DPV registry","volume":"106","author":"Prinz","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2022.110031_b0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2004.03.001","article-title":"DEBS Study Group a fourfold difference in the incidence of Type 1 diabetes between Sweden and Lithuania but similar prevalence of autoimmunity","volume":"66","author":"Samuelsson","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.110031_b0095","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/jcm10071536","article-title":"Clinical characteristics and degree of glycemic and cardiovascular risk factor control in patients with Type 1 diabetes in Catalonia (Spain)","volume":"10","author":"Gimenez-Perez","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2022.110031_b0100","doi-asserted-by":"crossref","unstructured":"Recalde M, Rodr\u00edguez C, Burn E, Far M, Garc\u00eda D, Carrere-Molina J, Ben\u00edtez M, Moleras A, Pistillo A, Bol\u00edbar B, Arag\u00f3n M, Duarte-Salles T. Data Resource Profile: The Information System for Research in Primary Care (SIDIAP). Int J Epidemiol. 2022 Apr 13:dyac068. doi: 10.1093\/ije\/dyac068.","DOI":"10.1093\/ije\/dyac068"},{"key":"10.1016\/j.diabres.2022.110031_b0105","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00125-022-05659-9","article-title":"Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts","volume":"65","author":"Ruiz","year":"2022","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.diabres.2022.110031_b0110","article-title":"Trends in the degree of control and treatment of cardiovascular risk factors in people with type 2 diabetes in a primary care setting in catalonia during 2007\u20132018","volume":"10","author":"Mata-Cases","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2022.110031_b0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2213-8587(21)00327-2","article-title":"Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data","volume":"10","author":"Magliano","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2022.110031_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v057.i12","article-title":"Building Bivariate Tables: the comparegroups package for R","volume":"57","author":"Subirana","year":"2014","journal-title":"J Stat Softw"},{"key":"10.1016\/j.diabres.2022.110031_b0125","unstructured":"R Core Team (2019). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.diabres.2022.110031_b0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/dc18-1157","article-title":"Late-onset T1DM and older age predict risk of additional autoimmune disease","volume":"42","author":"Hughes","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110031_b0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00400928","article-title":"Incidence of type 1 (insulin-dependent) diabetes mellitus in catalonia, spain. the catalan epidemiology diabetes study group","volume":"35","author":"Goday","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.110031_b0140","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/dc16-2508","volume":"40","author":"Craig","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110031_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102423","article-title":"Comparative United States autoimmune disease rates for 2010\u20132016 by sex, geographic region, and race","volume":"19","author":"Roberts","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.diabres.2022.110031_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032487","article-title":"Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity","volume":"7","author":"Sardu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2022.110031_b0155","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee: Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M. Comprehensive medical evaluation and assessment of comorbidities: Standards of medical care in diabetes-2022. Diabetes Care 2022;45(Suppl 1):S46-S59. DOI:10.2337\/dc22-S004.","DOI":"10.2337\/dc22-S004"},{"key":"10.1016\/j.diabres.2022.110031_b0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1530\/EJE-18-0515","article-title":"Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis","volume":"180","author":"Nederstigt","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2022.110031_b0165","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jdiacomp.2015.12.027","article-title":"Incidence and prevalence of thyroid dysfunction in type 1 diabetes","volume":"30","author":"Nederstigt","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2022.110031_b0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ad.2020.11.017","article-title":"Burden of psoriasis in Catalonia: epidemiology, associated comorbidities, health care utilization, and sick leave","volume":"112","author":"Puig","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.diabres.2022.110031_b0175","doi-asserted-by":"crossref","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. Global Psoriasis Atlas. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020 May 28;369:m1590. DOI:10.1136\/bmj.m1590.","DOI":"10.1136\/bmj.m1590"},{"key":"10.1016\/j.diabres.2022.110031_b0180","doi-asserted-by":"crossref","first-page":"6219730","DOI":"10.1155\/2016\/6219730","article-title":"Effect of associated autoimmune adiseases on Type 1 diabetes mellitus incidence and metabolic control in children and adolescents","volume":"2016","author":"Krzewska","year":"2016","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/j.diabres.2022.110031_b0185","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fendo.2019.00889","article-title":"Hypothyroidism and adverse endpoints in diabetic patients: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2022.110031_b0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1573399812666151029101622","article-title":"Association of hypothyroidism with body mass index, systolic blood pressure and proteinuria in diabetic patients: does treated hypothyroidism with thyroxine replacement therapy prevent nephropathy\/chronic renal disease?","volume":"12","author":"Aziz","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.diabres.2022.110031_b0195","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2022.110031_b0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/5584_2020_533","article-title":"Latent autoimmune diabetes in adults: a review of clinically relevant issues","volume":"1307","author":"Hern\u00e1ndez","year":"2021","journal-title":"Adv Exp Med Biol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:22:42Z","timestamp":1759173762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"alternative-id":["S0168822722008452"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110031","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110031"}}